Concepts (325)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| World Health Organization | 27 | 2021 | 4213 | 3.84 | Why? |
| Global Health | 43 | 2021 | 13911 | 3.72 | Why? |
| Civil Rights | 9 | 2020 | 113 | 3.62 | Why? |
| Supreme Court Decisions | 4 | 2020 | 17 | 3.16 | Why? |
| Government Regulation | 12 | 2020 | 842 | 2.98 | Why? |
| International Cooperation | 19 | 2020 | 3436 | 2.75 | Why? |
| Politics | 16 | 2021 | 1824 | 2.45 | Why? |
| Health Policy | 20 | 2021 | 6242 | 2.27 | Why? |
| State Government | 7 | 2020 | 416 | 2.20 | Why? |
| Taxes | 4 | 2018 | 66 | 2.18 | Why? |
| Carbonated Beverages | 3 | 2018 | 45 | 2.07 | Why? |
| Mandatory Programs | 3 | 2021 | 291 | 1.84 | Why? |
| Human Rights | 10 | 2020 | 618 | 1.83 | Why? |
| Public Health | 20 | 2021 | 16359 | 1.77 | Why? |
| Federal Government | 8 | 2020 | 562 | 1.74 | Why? |
| Reproductive Rights | 4 | 2020 | 89 | 1.62 | Why? |
| Hemorrhagic Fever, Ebola | 7 | 2019 | 1475 | 1.51 | Why? |
| Social Justice | 5 | 2018 | 706 | 1.49 | Why? |
| Abortion, Legal | 2 | 2019 | 67 | 1.40 | Why? |
| Patient Protection and Affordable Care Act | 3 | 2020 | 164 | 1.37 | Why? |
| United States | 50 | 2021 | 46150 | 1.23 | Why? |
| Health Care Reform | 3 | 2018 | 409 | 1.18 | Why? |
| Health Services Accessibility | 11 | 2020 | 10697 | 1.13 | Why? |
| Communicable Disease Control | 15 | 2021 | 29620 | 1.08 | Why? |
| United States Dept. of Health and Human Services | 3 | 2019 | 71 | 1.06 | Why? |
| Public Health Practice | 4 | 2020 | 945 | 0.99 | Why? |
| Commerce | 3 | 2021 | 1109 | 0.97 | Why? |
| Epidemics | 7 | 2020 | 6407 | 0.95 | Why? |
| Health Equity | 6 | 2021 | 1223 | 0.95 | Why? |
| Health Education | 4 | 2020 | 1539 | 0.92 | Why? |
| Religion and Medicine | 2 | 2020 | 79 | 0.90 | Why? |
| Leadership | 8 | 2021 | 2241 | 0.89 | Why? |
| United Nations | 6 | 2020 | 367 | 0.87 | Why? |
| Insurance Coverage | 2 | 2019 | 348 | 0.85 | Why? |
| Firearms | 3 | 2020 | 238 | 0.85 | Why? |
| Human Experimentation | 2 | 2017 | 146 | 0.84 | Why? |
| Research Subjects | 2 | 2017 | 178 | 0.83 | Why? |
| Ethics, Professional | 1 | 2019 | 21 | 0.80 | Why? |
| Refugees | 3 | 2019 | 809 | 0.79 | Why? |
| Conscience | 1 | 2019 | 18 | 0.79 | Why? |
| Diplomacy | 1 | 2020 | 54 | 0.78 | Why? |
| Refusal to Treat | 1 | 2019 | 49 | 0.76 | Why? |
| Organizational Policy | 2 | 2021 | 694 | 0.75 | Why? |
| Censorship, Research | 1 | 2018 | 8 | 0.74 | Why? |
| Social Control, Formal | 2 | 2019 | 165 | 0.74 | Why? |
| Dietary Sucrose | 1 | 2018 | 15 | 0.73 | Why? |
| Women's Rights | 1 | 2019 | 61 | 0.73 | Why? |
| Disabled Persons | 2 | 2020 | 1152 | 0.71 | Why? |
| Food Industry | 2 | 2018 | 197 | 0.71 | Why? |
| Relief Work | 2 | 2020 | 185 | 0.71 | Why? |
| Health Insurance Portability and Accountability Act | 1 | 2018 | 69 | 0.70 | Why? |
| Public Health Administration | 3 | 2021 | 846 | 0.70 | Why? |
| Needle-Exchange Programs | 1 | 2019 | 146 | 0.70 | Why? |
| Health Records, Personal | 1 | 2018 | 63 | 0.70 | Why? |
| Privatization | 1 | 2017 | 13 | 0.69 | Why? |
| Medical Marijuana | 1 | 2018 | 55 | 0.67 | Why? |
| Starvation | 1 | 2017 | 34 | 0.67 | Why? |
| Health Promotion | 4 | 2020 | 2020 | 0.66 | Why? |
| Lead Poisoning | 1 | 2016 | 9 | 0.65 | Why? |
| Mandatory Reporting | 1 | 2018 | 140 | 0.64 | Why? |
| Drug and Narcotic Control | 1 | 2018 | 134 | 0.63 | Why? |
| Child Nutrition Disorders | 1 | 2017 | 86 | 0.61 | Why? |
| Environmental Policy | 1 | 2017 | 88 | 0.60 | Why? |
| Civil Defense | 2 | 2017 | 1687 | 0.57 | Why? |
| Pandemics | 34 | 2021 | 389249 | 0.57 | Why? |
| Science | 2 | 2021 | 463 | 0.57 | Why? |
| Obesity | 4 | 2018 | 7388 | 0.56 | Why? |
| National Institutes of Health (U.S.) | 1 | 2017 | 443 | 0.55 | Why? |
| Environmental Health | 1 | 2017 | 203 | 0.55 | Why? |
| Substance Abuse, Intravenous | 1 | 2019 | 411 | 0.54 | Why? |
| International Law | 3 | 2020 | 34 | 0.54 | Why? |
| Persistent Vegetative State | 1 | 2014 | 34 | 0.54 | Why? |
| Bioethical Issues | 1 | 2017 | 233 | 0.53 | Why? |
| Democratic Republic of the Congo | 4 | 2019 | 500 | 0.53 | Why? |
| Humans | 105 | 2021 | 930598 | 0.53 | Why? |
| Administrative Personnel | 1 | 2017 | 326 | 0.53 | Why? |
| Poliomyelitis | 1 | 2018 | 263 | 0.52 | Why? |
| Tobacco Products | 1 | 2017 | 245 | 0.52 | Why? |
| Down Syndrome | 1 | 2018 | 397 | 0.51 | Why? |
| Nutrition Policy | 1 | 2015 | 132 | 0.51 | Why? |
| Coronavirus Infections | 28 | 2020 | 253789 | 0.51 | Why? |
| Health Planning | 1 | 2020 | 607 | 0.51 | Why? |
| Water Supply | 1 | 2016 | 294 | 0.51 | Why? |
| Environment Design | 1 | 2015 | 183 | 0.50 | Why? |
| Vaccination Coverage | 2 | 2020 | 1249 | 0.50 | Why? |
| Confidentiality | 1 | 2018 | 581 | 0.50 | Why? |
| Pneumonia, Viral | 27 | 2020 | 243684 | 0.50 | Why? |
| Organophosphorus Compounds | 1 | 2012 | 53 | 0.50 | Why? |
| Motor Activity | 1 | 2015 | 217 | 0.50 | Why? |
| Security Measures | 3 | 2020 | 211 | 0.49 | Why? |
| Drug Resistance, Microbial | 1 | 2017 | 419 | 0.49 | Why? |
| Life Support Care | 1 | 2014 | 161 | 0.48 | Why? |
| Professional-Family Relations | 1 | 2017 | 424 | 0.48 | Why? |
| Acquired Immunodeficiency Syndrome | 1 | 2019 | 533 | 0.48 | Why? |
| Brain Death | 1 | 2014 | 146 | 0.46 | Why? |
| One Health | 1 | 2017 | 390 | 0.46 | Why? |
| Travel | 6 | 2021 | 7220 | 0.46 | Why? |
| Deoxycytidine | 1 | 2012 | 116 | 0.46 | Why? |
| Climate Change | 2 | 2017 | 901 | 0.45 | Why? |
| Unsafe Sex | 1 | 2012 | 139 | 0.45 | Why? |
| Emigration and Immigration | 1 | 2017 | 501 | 0.45 | Why? |
| Vaccination | 7 | 2021 | 19050 | 0.44 | Why? |
| Schools | 3 | 2021 | 4187 | 0.43 | Why? |
| Disaster Planning | 3 | 2020 | 1680 | 0.43 | Why? |
| Triage | 2 | 2020 | 7151 | 0.42 | Why? |
| Empathy | 1 | 2017 | 658 | 0.41 | Why? |
| Legislation, Medical | 2 | 2019 | 66 | 0.41 | Why? |
| Betacoronavirus | 24 | 2020 | 204454 | 0.41 | Why? |
| Quarantine | 5 | 2020 | 18418 | 0.40 | Why? |
| Informed Consent | 1 | 2017 | 890 | 0.39 | Why? |
| Papillomavirus Infections | 1 | 2018 | 861 | 0.39 | Why? |
| Insurance, Health | 2 | 2017 | 634 | 0.39 | Why? |
| Emergencies | 6 | 2020 | 4095 | 0.39 | Why? |
| Data Collection | 1 | 2018 | 1769 | 0.37 | Why? |
| Influenza, Human | 4 | 2020 | 10779 | 0.37 | Why? |
| Biomedical Research | 3 | 2020 | 5270 | 0.37 | Why? |
| Intellectual Property | 2 | 2020 | 76 | 0.35 | Why? |
| Breast Feeding | 1 | 2019 | 1585 | 0.35 | Why? |
| Government | 1 | 2017 | 1453 | 0.34 | Why? |
| Withholding Treatment | 1 | 2014 | 798 | 0.34 | Why? |
| Analgesics, Opioid | 1 | 2017 | 1070 | 0.34 | Why? |
| Veterans | 1 | 2018 | 1131 | 0.34 | Why? |
| Internationality | 5 | 2020 | 3297 | 0.34 | Why? |
| International Agencies | 3 | 2018 | 202 | 0.34 | Why? |
| Information Dissemination | 2 | 2020 | 2986 | 0.33 | Why? |
| Transients and Migrants | 1 | 2019 | 1468 | 0.32 | Why? |
| Health Resources | 1 | 2020 | 2592 | 0.32 | Why? |
| Prisoners | 2 | 2007 | 738 | 0.32 | Why? |
| Immunization Programs | 1 | 2019 | 2006 | 0.31 | Why? |
| Healthcare Disparities | 2 | 2021 | 3893 | 0.31 | Why? |
| Patents as Topic | 2 | 2021 | 224 | 0.31 | Why? |
| Ethics, Medical | 1 | 2012 | 533 | 0.30 | Why? |
| Quality of Health Care | 1 | 2017 | 1948 | 0.30 | Why? |
| Public Policy | 2 | 2017 | 1894 | 0.30 | Why? |
| Environmental Exposure | 1 | 2016 | 1558 | 0.29 | Why? |
| Opioid-Related Disorders | 1 | 2017 | 1185 | 0.29 | Why? |
| Altruism | 2 | 2020 | 300 | 0.29 | Why? |
| Viral Vaccines | 3 | 2020 | 7560 | 0.28 | Why? |
| Disease Outbreaks | 7 | 2021 | 27595 | 0.27 | Why? |
| Influenza Vaccines | 1 | 2020 | 2941 | 0.26 | Why? |
| Health Status Disparities | 3 | 2020 | 4072 | 0.26 | Why? |
| Local Government | 2 | 2019 | 301 | 0.26 | Why? |
| Anti-Retroviral Agents | 1 | 2012 | 1099 | 0.26 | Why? |
| Survival | 2 | 2020 | 53 | 0.26 | Why? |
| History, 21st Century | 3 | 2021 | 1849 | 0.26 | Why? |
| Research Support as Topic | 2 | 2017 | 327 | 0.25 | Why? |
| Palliative Care | 1 | 2017 | 2665 | 0.24 | Why? |
| Patient Rights | 1 | 2003 | 84 | 0.24 | Why? |
| History, 20th Century | 2 | 2019 | 1282 | 0.24 | Why? |
| Pharmaceutical Preparations | 1 | 2017 | 1897 | 0.24 | Why? |
| Transportation | 2 | 2021 | 691 | 0.23 | Why? |
| Mental Competency | 1 | 2003 | 128 | 0.23 | Why? |
| National Health Programs | 2 | 2021 | 807 | 0.22 | Why? |
| Forecasting | 4 | 2020 | 4492 | 0.22 | Why? |
| Medicaid | 2 | 2020 | 492 | 0.22 | Why? |
| Texas | 2 | 2019 | 1237 | 0.22 | Why? |
| Drug Industry | 2 | 2021 | 689 | 0.22 | Why? |
| Treatment Refusal | 1 | 2003 | 211 | 0.22 | Why? |
| Vulnerable Populations | 4 | 2020 | 3099 | 0.21 | Why? |
| Virus Diseases | 2 | 2020 | 3779 | 0.21 | Why? |
| Health Facility Administration | 1 | 2021 | 54 | 0.21 | Why? |
| Mitochondrial Replacement Therapy | 1 | 2019 | 3 | 0.21 | Why? |
| Legal Services | 1 | 2019 | 6 | 0.20 | Why? |
| Famous Persons | 1 | 2020 | 74 | 0.20 | Why? |
| Smallpox Vaccine | 1 | 2019 | 46 | 0.19 | Why? |
| Specimen Handling | 1 | 2017 | 6190 | 0.19 | Why? |
| Mitochondrial Diseases | 1 | 2019 | 62 | 0.19 | Why? |
| Financing, Organized | 1 | 2020 | 137 | 0.19 | Why? |
| World War II | 1 | 2018 | 16 | 0.19 | Why? |
| Partnership Practice | 1 | 2018 | 12 | 0.18 | Why? |
| Economics | 1 | 2020 | 196 | 0.18 | Why? |
| Product Labeling | 1 | 2018 | 41 | 0.18 | Why? |
| United States Office of Research Integrity | 1 | 2017 | 2 | 0.18 | Why? |
| Government Agencies | 1 | 2020 | 248 | 0.18 | Why? |
| Child Health | 2 | 2018 | 940 | 0.17 | Why? |
| Socioeconomic Factors | 4 | 2021 | 8495 | 0.17 | Why? |
| Somalia | 1 | 2017 | 62 | 0.17 | Why? |
| Masks | 1 | 2020 | 8528 | 0.17 | Why? |
| Droughts | 1 | 2017 | 30 | 0.17 | Why? |
| International Educational Exchange | 1 | 2017 | 19 | 0.17 | Why? |
| Ebola Vaccines | 1 | 2019 | 126 | 0.17 | Why? |
| Trust | 2 | 2020 | 1487 | 0.17 | Why? |
| Legislation, Drug | 1 | 2018 | 101 | 0.17 | Why? |
| Africa, Western | 1 | 2018 | 363 | 0.17 | Why? |
| Yemen | 1 | 2017 | 136 | 0.17 | Why? |
| Sudan | 1 | 2017 | 166 | 0.17 | Why? |
| Poliovirus | 1 | 2018 | 109 | 0.16 | Why? |
| Patient Acceptance of Health Care | 3 | 2020 | 5002 | 0.16 | Why? |
| Guidelines as Topic | 3 | 2021 | 2844 | 0.16 | Why? |
| Syria | 1 | 2017 | 170 | 0.16 | Why? |
| Quality of Life | 1 | 2018 | 9820 | 0.16 | Why? |
| Poliovirus Vaccine, Oral | 1 | 2018 | 95 | 0.16 | Why? |
| Decision Making | 3 | 2020 | 3132 | 0.16 | Why? |
| Morals | 2 | 2018 | 483 | 0.16 | Why? |
| Social Discrimination | 1 | 2020 | 269 | 0.16 | Why? |
| Intersectoral Collaboration | 2 | 2020 | 1065 | 0.16 | Why? |
| Reproductive Health Services | 1 | 2019 | 222 | 0.16 | Why? |
| Smoking Prevention | 1 | 2017 | 116 | 0.15 | Why? |
| Hope | 1 | 2018 | 210 | 0.15 | Why? |
| Interdisciplinary Research | 1 | 2018 | 266 | 0.15 | Why? |
| Prejudice | 1 | 2019 | 245 | 0.15 | Why? |
| Measles Vaccine | 1 | 2019 | 301 | 0.15 | Why? |
| Liability, Legal | 1 | 2019 | 198 | 0.15 | Why? |
| Ohio | 1 | 2018 | 639 | 0.15 | Why? |
| Budgets | 1 | 2017 | 155 | 0.15 | Why? |
| Health Priorities | 3 | 2020 | 959 | 0.15 | Why? |
| Transgender Persons | 1 | 2019 | 322 | 0.14 | Why? |
| Disease Notification | 1 | 2021 | 639 | 0.14 | Why? |
| Genetic Testing | 1 | 2018 | 395 | 0.14 | Why? |
| Health Behavior | 1 | 2013 | 4449 | 0.14 | Why? |
| Influenza A Virus, H1N1 Subtype | 1 | 2009 | 2984 | 0.14 | Why? |
| Ethics Committees, Research | 1 | 2017 | 272 | 0.14 | Why? |
| Program Development | 1 | 2021 | 1089 | 0.13 | Why? |
| Privacy | 1 | 2020 | 636 | 0.13 | Why? |
| Europe | 3 | 2021 | 12702 | 0.13 | Why? |
| Computer Security | 1 | 2018 | 408 | 0.13 | Why? |
| Crowding | 1 | 2020 | 731 | 0.13 | Why? |
| Water Microbiology | 1 | 2016 | 248 | 0.13 | Why? |
| Life Expectancy | 1 | 2019 | 474 | 0.13 | Why? |
| Goals | 1 | 2017 | 335 | 0.13 | Why? |
| Travel-Related Illness | 1 | 2021 | 1357 | 0.13 | Why? |
| Child | 7 | 2020 | 70012 | 0.13 | Why? |
| Developing Countries | 3 | 2021 | 4283 | 0.13 | Why? |
| Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination | 1 | 2012 | 14 | 0.13 | Why? |
| Drug Costs | 1 | 2017 | 313 | 0.13 | Why? |
| Conservation of Natural Resources | 1 | 2018 | 520 | 0.13 | Why? |
| Marketing | 1 | 2015 | 195 | 0.12 | Why? |
| Developed Countries | 1 | 2017 | 500 | 0.12 | Why? |
| HIV Seronegativity | 1 | 2012 | 112 | 0.12 | Why? |
| Ebolavirus | 2 | 2019 | 834 | 0.12 | Why? |
| Michigan | 1 | 2016 | 988 | 0.12 | Why? |
| Hospitals, Urban | 1 | 2017 | 950 | 0.12 | Why? |
| Neglected Diseases | 1 | 2017 | 381 | 0.12 | Why? |
| Health Care Rationing | 3 | 2021 | 2558 | 0.12 | Why? |
| Financing, Government | 1 | 2017 | 434 | 0.12 | Why? |
| Health Facilities | 1 | 2020 | 1230 | 0.11 | Why? |
| HIV | 1 | 2019 | 1116 | 0.11 | Why? |
| Emigrants and Immigrants | 1 | 2020 | 888 | 0.11 | Why? |
| Congresses as Topic | 1 | 2021 | 1347 | 0.11 | Why? |
| Africa | 1 | 2020 | 2986 | 0.11 | Why? |
| Family Relations | 1 | 2014 | 288 | 0.11 | Why? |
| Personal Autonomy | 1 | 2014 | 313 | 0.11 | Why? |
| HIV Infections | 2 | 2017 | 11620 | 0.11 | Why? |
| Policy | 1 | 2019 | 1372 | 0.11 | Why? |
| Communicable Diseases, Imported | 1 | 2019 | 843 | 0.10 | Why? |
| Abortion, Induced | 1 | 2017 | 437 | 0.10 | Why? |
| Contact Tracing | 2 | 2021 | 8448 | 0.10 | Why? |
| New York | 1 | 2018 | 2488 | 0.10 | Why? |
| Minority Groups | 1 | 2020 | 1631 | 0.10 | Why? |
| Resource Allocation | 1 | 2021 | 1771 | 0.10 | Why? |
| Nigeria | 1 | 2017 | 2292 | 0.10 | Why? |
| Medically Underserved Area | 1 | 2012 | 273 | 0.10 | Why? |
| Reagent Kits, Diagnostic | 1 | 2020 | 2149 | 0.10 | Why? |
| Health Communication | 1 | 2020 | 1120 | 0.10 | Why? |
| Noncommunicable Diseases | 1 | 2018 | 934 | 0.09 | Why? |
| Employment | 1 | 2020 | 1754 | 0.09 | Why? |
| Models, Organizational | 1 | 2015 | 908 | 0.09 | Why? |
| Smartphone | 1 | 2020 | 1840 | 0.09 | Why? |
| Mexico | 1 | 2017 | 2787 | 0.09 | Why? |
| Workplace | 1 | 2021 | 2075 | 0.09 | Why? |
| China | 3 | 2021 | 50654 | 0.09 | Why? |
| Eligibility Determination | 1 | 2010 | 255 | 0.09 | Why? |
| Physician-Patient Relations | 1 | 2018 | 1266 | 0.09 | Why? |
| Attitude to Health | 1 | 2021 | 2002 | 0.08 | Why? |
| Evidence-Based Medicine | 1 | 2020 | 3228 | 0.08 | Why? |
| California | 1 | 2014 | 2047 | 0.08 | Why? |
| Motivation | 1 | 2017 | 1640 | 0.08 | Why? |
| Surveys and Questionnaires | 4 | 2021 | 43792 | 0.08 | Why? |
| Pregnancy | 2 | 2019 | 23879 | 0.08 | Why? |
| Universities | 1 | 2021 | 4374 | 0.08 | Why? |
| Female | 10 | 2020 | 380317 | 0.08 | Why? |
| Communication | 2 | 2020 | 5206 | 0.07 | Why? |
| Occupational Diseases | 1 | 2020 | 2787 | 0.07 | Why? |
| Organizational Innovation | 1 | 2015 | 2468 | 0.07 | Why? |
| Zika Virus | 1 | 2017 | 1924 | 0.07 | Why? |
| New York City | 1 | 2017 | 7432 | 0.07 | Why? |
| Zika Virus Infection | 1 | 2017 | 1920 | 0.06 | Why? |
| Sexual Behavior | 1 | 2012 | 1322 | 0.06 | Why? |
| Coercion | 1 | 2003 | 57 | 0.06 | Why? |
| Population Surveillance | 2 | 2020 | 4967 | 0.06 | Why? |
| Drug Combinations | 1 | 2012 | 3852 | 0.06 | Why? |
| Cost-Benefit Analysis | 1 | 2012 | 2259 | 0.06 | Why? |
| Incidence | 2 | 2021 | 25622 | 0.06 | Why? |
| Freedom | 1 | 2003 | 110 | 0.06 | Why? |
| Patient Isolation | 1 | 2015 | 3182 | 0.06 | Why? |
| Vaccines | 1 | 2019 | 3692 | 0.05 | Why? |
| Risk | 1 | 2012 | 5288 | 0.05 | Why? |
| Male | 7 | 2020 | 367725 | 0.05 | Why? |
| Social Responsibility | 1 | 2003 | 363 | 0.04 | Why? |
| DNA, Mitochondrial | 1 | 2019 | 163 | 0.04 | Why? |
| Infectious Disease Transmission, Patient-to-Professional | 1 | 2021 | 9706 | 0.04 | Why? |
| Disease Transmission, Infectious | 1 | 2021 | 9044 | 0.04 | Why? |
| Aged, 80 and over | 2 | 2018 | 88759 | 0.04 | Why? |
| Adult | 4 | 2020 | 244371 | 0.04 | Why? |
| Benchmarking | 1 | 2020 | 627 | 0.04 | Why? |
| Critical Care | 1 | 2020 | 14081 | 0.04 | Why? |
| Capacity Building | 1 | 2020 | 683 | 0.03 | Why? |
| Hospitals | 1 | 2014 | 11793 | 0.03 | Why? |
| Educational Status | 1 | 2020 | 1451 | 0.03 | Why? |
| Young Adult | 3 | 2020 | 93724 | 0.03 | Why? |
| Evidence-Based Practice | 1 | 2020 | 693 | 0.03 | Why? |
| Middle East Respiratory Syndrome Coronavirus | 1 | 2015 | 8843 | 0.03 | Why? |
| Violence | 1 | 2019 | 534 | 0.03 | Why? |
| Regression Analysis | 1 | 2020 | 2484 | 0.03 | Why? |
| Clinical Laboratory Techniques | 1 | 2020 | 23402 | 0.03 | Why? |
| United States Food and Drug Administration | 1 | 2019 | 1276 | 0.03 | Why? |
| Interprofessional Relations | 1 | 2018 | 1013 | 0.03 | Why? |
| Health Personnel | 1 | 2020 | 29646 | 0.03 | Why? |
| Drug Approval | 1 | 2019 | 1325 | 0.02 | Why? |
| Animals | 1 | 2017 | 78931 | 0.02 | Why? |
| Antiviral Agents | 1 | 2020 | 41703 | 0.02 | Why? |
| Parents | 1 | 2019 | 2758 | 0.02 | Why? |
| Caregivers | 1 | 2019 | 3112 | 0.02 | Why? |
| Sex Factors | 1 | 2020 | 11014 | 0.02 | Why? |
| Age Factors | 1 | 2020 | 21039 | 0.01 | Why? |
| Mutation | 1 | 2019 | 12376 | 0.01 | Why? |
| United Kingdom | 1 | 2019 | 18046 | 0.01 | Why? |
| Adolescent | 2 | 2020 | 86841 | 0.01 | Why? |
| Infant, Newborn | 1 | 2018 | 23105 | 0.01 | Why? |
| Delivery of Health Care | 1 | 2003 | 15909 | 0.01 | Why? |
| Infant | 1 | 2018 | 30274 | 0.01 | Why? |
| Child, Preschool | 1 | 2018 | 36283 | 0.01 | Why? |
| Middle Aged | 2 | 2020 | 270681 | 0.01 | Why? |
| Risk Factors | 1 | 2018 | 71621 | 0.01 | Why? |
| Aged | 1 | 2020 | 215776 | 0.00 | Why? |